首页> 外文期刊>Biomarkers in medicine >Association of Cyr61-cysteine-rich protein 61 and short-term mortality in patients with acute heart failure and coronary heart disease
【24h】

Association of Cyr61-cysteine-rich protein 61 and short-term mortality in patients with acute heart failure and coronary heart disease

机译:富含急性心力衰竭和冠心病患者的Cyr61-半胱氨酸蛋白61和短期死亡率

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: The protein CCN1/CYR61 exerts critical functions in myocardial ischemic injury. We sought to investigate the prognostic value of CCN1 in patients with acute heart failure (AHF) and coronary heart disease (CAD). Methodology: We prospectively enrolled 113 patients with AHF and CAD. Patients were followed for all-cause mortality during a 30-day follow-up. Logistic models were used to estimate the association of CCN1 concentrations with 30-day mortality. Results: In multivariate logistic regression model, CCN1 was a significant predictor of 30-day mortality independent of current markers. Enhanced Feedback for Effective Cardiac Treatment risk score was recommended as one of the selected multivariable risk scores to predict outcome in AHF. CCN1 improved risk stratification for all-cause mortality when added to the Enhanced Feedback for Effective Cardiac Treatment risk scores at 30 days. Conclusion: We found CCN1 is independently associated with 30-day mortality in patients with AHF and CAD.
机译:目的:蛋白质CCN1 / Cyr61在心肌缺血性损伤中发挥关键功能。我们试图探讨CCN1在急性心力衰竭(AHF)和冠心病(CAD)患者中的预后价值。方法论:我们展示了113名AHF和CAD患者。在30天的随访期间,患者被患者进行全面死亡率。物流模型用于估计CCN1浓度与30天死亡率的关联。结果:在多变量逻辑回归模型中,CCN1是30天死亡率的重要预测因子,独立于当前标记。建议使用有效心脏治疗风险评分的增强反馈作为预测AHF预测结果的选定多变量的风险评分之一。 CCN1在增加30天内添加到有效的心脏治疗风险分数的增强反馈时,CCN1改善了全导致死亡率的风险分层。结论:我们发现CCN1与AHF和CAD患者的30天死亡率独立相关。

著录项

  • 来源
    《Biomarkers in medicine》 |2019年第18期|共9页
  • 作者单位

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Guizhou Prov Peoples Hosp Dept Cardiol Guiyang 550001 Guizhou Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Southern Med Univ Dept Anesthesiol Nanfang Hosp Guangzhou 510515 Guangdong Peoples R China;

    Hainan Gen Hosp Dept Cardiol Haikou 570311 Hainan Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Cardiol Guangzhou 510080 Guangdong Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 预防医学、卫生学;
  • 关键词

    acute heart failure; CCN1/CYR61; coronary heart disease; Cyr61-cysteine-rich protein 61; prognosis;

    机译:急性心力衰竭;CCN1 / Cyr61;冠心病;Cyr61-半胱氨酸蛋白61;预后;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号